Metraipolis › archive › dc_588ce3e1a41e

Gut metabolites: key factors in the cross-talk between the gut microbiota and tumor immunotherapy — Europe PMC PMID:42558660

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42558660
DOI
10.3389/fimmu.2026.1882542
License (as archived)
solo-consultazione
Archived
2026-10-17T23:55:21.314Z
SHA-256 of the archived text
93171183a133dda7df1c55a1d7f71aaf5eae2c603090bf6dba37d3c169c884d3
Stable URL of this page
https://metraipolis.com/documento/dc_588ce3e1a41e

How to cite

Gut metabolites: key factors in the cross-talk between the gut microbiota and tumor immunotherapy — Europe PMC PMID:42558660 — Europe PMC (en), https://europepmc.org/article/MED/42558660 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_588ce3e1a41e (Metraipolis archive dc_588ce3e1a41e, sha256 93171183a133dda7df1c55a1d7f71aaf5eae2c603090bf6dba37d3c169c884d3)
BibTeX
@misc{dc588ce3e1a41e,
  title = {Gut metabolites: key factors in the cross-talk between the gut microbiota and tumor immunotherapy — Europe PMC PMID:42558660},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42558660},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_588ce3e1a41e; sha256 93171183a133dda7df1c55a1d7f71aaf5eae2c603090bf6dba37d3c169c884d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42558660. Agents can read the archived copy with the MCP tool read_document.